ACTRN12610000068066已完成1 期
A phase 1 study to assess the safety of mesenchymal stromal cells to treat steroid-refractory graft versus host disease after allogeneic haemopoietic stem cell tranplantation.
R.P.Herrmann0 个研究点目标入组 20 人开始时间: 2010年1月20日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 60 Years（—）
- 性别
- All
入选标准
- •Steroid-refractory graft versus host disease post allogeneic haemopoietic stem cell transplant
- •Informed consent given
排除标准
- •No informed consent
研究者
相似试验
招募中
1 期
Comparison of the efficacy of mesenchymal stem cells condition medium injection and ow level laser in the treatment of alopeciaIRCT20200127046282N27Shahid Beheshti University of Medical Sciences30
招募中
1 期
Evaluation of the safety and effectiveness of mesenchymal stem cells conditioned medium in the treatment of hair lossHair loss.Nonscarring hair loss, unspecifiedL65.9IRCT20200127046282N13Tehran University of Medical Sciences45
已完成
不适用
Evaluation of safety and tolerability of mesenchymal stem cell mobilization factor KOI2 (Phase 1 study )Epidermolysis bullosaJPRN-UMIN000018252Osaka University Hospital48
尚未招募
1 期
A safety study of autologous mesenchymal precursor cells (MPCs) in the management of delayed healing tibial fractures requiring secondary surgical intervention to promote fracture union.Delayed or non-union tibial fractureMusculoskeletal - FracturesACTRN12605000051640Mesoblast10
进行中（未招募）
1 期
A prospective phase I/II study to evaluate the use of mesenchymal stromal (stem) cells for the treatment of skin disease in adults with recessive dystrophic epidermolysis bullosaRecessive dystrophic epidermolysis bullosaEUCTR2014-004500-30-GBKing's College London10